The renowned pharmaceutical maker and corporation Sudarshan Pharma Industries, based in Mumbai, India, announced a 1:10 stock ...
Nandan Nilekani discussed India's digital public infrastructure plans and the rise of account aggregators, supported by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback